Greenville, S.C. – August 25, 2026 – Supira Medical recently highlighted a major regional milestone on LinkedIn, welcoming Prisma Health Heart and Vascular Institute as the first program in the Southeastern United States to enroll a patient in the SUPPORT II pivotal study.

LinkedIn post announcing Prisma Health Heart and Vascular Institute as the first in the Southeastern US to enroll a patient in the SUPPORT II trial.